Eulav Asset Management Has Upped Tesla (TSLA) Holding By $3.41 Million; Biolase Has 0.79 Sentiment

January 14, 2018 - By Adrian Erickson

Eulav Asset Management increased Tesla Inc (TSLA) stake by 111.11% reported in 2017Q3 SEC filing. Eulav Asset Management acquired 10,000 shares as Tesla Inc (TSLA)’s stock rose 14.18%. The Eulav Asset Management holds 19,000 shares with $6.48M value, up from 9,000 last quarter. Tesla Inc now has $56.51 billion valuation. The stock decreased 0.51% or $1.73 during the last trading session, reaching $336.22. About 4.83M shares traded. Tesla, Inc. (NASDAQ:TSLA) has risen 44.43% since January 14, 2017 and is uptrending. It has outperformed by 27.73% the S&P500.

BIOLASE, Inc., a medical device company, develops, makes, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company has market cap of $38.03 million. The firm offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It currently has negative earnings. The Company’s dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications.

Among 34 analysts covering Tesla Motors Inc (NASDAQ:TSLA), 11 have Buy rating, 10 Sell and 13 Hold. Therefore 32% are positive. Tesla Motors Inc had 118 analyst reports since July 21, 2015 according to SRatingsIntel. On Friday, September 29 the stock rating was maintained by Robert W. Baird with “Buy”. The stock of Tesla, Inc. (NASDAQ:TSLA) has “Outperform” rating given on Tuesday, April 5 by Credit Suisse. The stock has “Market Perform” rating by JMP Securities on Monday, December 14. Piper Jaffray maintained it with “Buy” rating and $386.0 target in Wednesday, September 27 report. On Friday, October 6 the stock rating was maintained by RBC Capital Markets with “Hold”. Barclays Capital maintained the shares of TSLA in report on Tuesday, February 9 with “Underweight” rating. Robert W. Baird maintained Tesla, Inc. (NASDAQ:TSLA) rating on Thursday, November 2. Robert W. Baird has “Buy” rating and $411.0 target. The company was maintained on Thursday, August 3 by Guggenheim. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, November 25 report. Goldman Sachs maintained the stock with “Sell” rating in Friday, June 30 report.

Since August 1, 2017, it had 0 insider purchases, and 8 sales for $19.84 million activity. Musk Kimbal sold $703,781 worth of stock. Another trade for 44,777 shares valued at $15.24M was sold by Jurvetson Stephen T. 1,400 shares valued at $476,944 were sold by FIELD JOHN DOUGLAS on Wednesday, December 13. On Tuesday, September 5 the insider Branderiz Eric sold $34,661.

Eulav Asset Management decreased Apple Inc (NASDAQ:AAPL) stake by 10,442 shares to 34,000 valued at $5.24 million in 2017Q3. It also reduced Verint Sys Inc (NASDAQ:VRNT) stake by 17,300 shares and now owns 27,500 shares. Xpo Logistics Inc (NYSE:XPO) was reduced too.

Investors sentiment increased to 1.3 in 2017 Q3. Its up 0.03, from 1.27 in 2017Q2. It is positive, as 93 investors sold TSLA shares while 134 reduced holdings. 73 funds opened positions while 223 raised stakes. 93.25 million shares or 1.29% more from 92.06 million shares in 2017Q2 were reported. Jane Street Limited Liability Corp accumulated 0.02% or 17,802 shares. Sei Invs Communication reported 81,960 shares. Fifth Third Bank & Trust reported 8,452 shares or 0.02% of all its holdings. Garde Capital has invested 0.21% in Tesla, Inc. (NASDAQ:TSLA). Carnegie Capital Asset Mngmt Lc stated it has 4,385 shares or 0.17% of all its holdings. Mirador Capital Prtn Limited Partnership holds 1% or 5,000 shares in its portfolio. Sns Gp Ltd Liability Corporation stated it has 763 shares. Wealth Architects Ltd Liability holds 947 shares. California-based Research Investors has invested 0.06% in Tesla, Inc. (NASDAQ:TSLA). Hl Fincl Ltd Liability Corporation holds 0.01% or 1,326 shares in its portfolio. 4,537 are held by Driehaus Capital Limited Liability Company. Geode Capital Mgmt Ltd Com holds 0.13% or 1.00M shares in its portfolio. 3,828 are owned by Old Mutual Customised Solutions (Proprietary) Limited. Great West Life Assurance Co Can reported 0.06% stake. Regions Fincl Corporation owns 1,244 shares.

Oracle Investment Management Inc holds 1.81% of its portfolio in BIOLASE, Inc. for 18.32 million shares. Birchview Capital Lp owns 1.29 million shares or 0.4% of their US portfolio. Moreover, Trellus Management Company Llc has 0.31% invested in the company for 375,028 shares. The Massachusetts-based Camber Capital Management Llc has invested 0.2% in the stock. Teton Advisors Inc., a New York-based fund reported 341,461 shares.

The stock decreased 5.59% or $0.0296 during the last trading session, reaching $0.5003. About 136,917 shares traded. BIOLASE, Inc. (BIOL) has risen 0.85% since January 14, 2017 and is uptrending. It has underperformed by 15.85% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News